Genetic and molecular criteria for the study of the most common hereditary cancers: A literature review
DOI:
https://doi.org/10.56294/saludcyt2024.1211Keywords:
Hereditary cancer, Genetic counseling, Genetic predisposition, Genetic diagnosis, Breast cancer, Colorectal cancerAbstract
Introduction: For centuries, cancer was interpreted as a divine punishment, and its treatment was based on rituals. However, the advancement of medicine led physicians to observe familial patterns, thus exploring potential genetic causes. Presently, genomics has unveiled the underlying complexity of cancer, offering new avenues for its prevention and treatment. This review focuses on hereditary cancers, proposing criteria for their study and genetic counseling, thereby providing a crucial guide for informed clinical decision-making. Objective: This study aims to deepen the current understanding of the most prevalent hereditary cancers, with a specific focus on their genetic bases. Methods: In this review, a detailed analysis of the literature was conducted using Scopus, PubMed, Google Scholar, and other online sources, employing specific keywords supported by specialized thesauri. Thirty-eight references focused on hereditary cancers published between 2019 and 2024 were carefully selected. Development: Exploring the genetic bases of cancer involves addressing the cell cycle, genetic regulation, and crucial genes such as p53. Cancer predisposing genes are identified, and common hereditary syndromes, such as hereditary breast and ovarian cancer, hereditary non-polyposis colorectal cancer, and familial adenomatous polyposis, are described. Conclusions: Cancer, influenced by genetic factors, manifests in specific mutations such as BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, and APC, increasing the risks of breast, ovarian, colorectal cancer, and familial adenomatous polyposis. The application of study criteria based on family history and genetic testing facilitates the identification of individuals and families prone to these mutations.
References
Lynch HT. The history of hereditary cancer. In: Sánchez ÁA, Orgaz MB, Guillermo IB, Vidal JBi, López JGF, Cámara JIM, et al., editors. Madrid: Dispublic, S.L.; 2006. p. 23-27. Available from: https://www.seom.org/seomcms/images/stories/recursos/infopublico/publicaciones/cancerHereditario/introduccion_cancer_hereditario.pdf
World Health Organization. World Health Organization. [Online]; 2023. Available from: https://www.paho.org/en/campaigns/world-cancer-day-2023-for-fairer-care.
Gutiérrez L, Jalil F, Solano A. Hereditary cancer: trust in knowledge overcomes doubts. 2020.
Ministerio de Salud Pública del Ecuador. Ministerio de Salud Pública del Ecuador. [Online]; 2022. Available from: https://www.salud.gob.ec/diagnostico-y-deteccion-oportunas-son-claves-para-detectar-el-cancer/#:~:text=Tasa%20de%20incidencia%20y%20mortalidad%20por%20c%C3%A1ncer%20en%20Ecuador&text=Se%20estima%20que%20cuatro%20millones,de%20edad%20o%20m%C3%A1s%20j%C3%B3.
National Human Genome Research Institute. Cell cycle. [Online]; 2024. Accessed February 2, 2024. Available from: https://www.genome.gov/genetics-glossary/Cell-cycle.
Lucero GS. Comparative analysis of the cytotoxicity of zinc oxide nanoparticles and their effect on the cell cycle of fibroblasts, osteoblasts, and melanoma. [Online]; 2020. Accessed February 2, 2024. Available from: https://cicese.repositorioinstitucional.mx/jspui/bitstream/1007/3311/3/tesis_Gloria%20Salinas%20Lucero_19%20oct%202020.pdf.
Lucero PAF, Terán NKM, Peralta DFG, Angamarca JVT, Loachamin MGG, Zambrano MIR, et al. Relationship Between Tumor Suppressor Genes and Oncogenes in Cancer Development. Braz J Hea Rev [Online]. 2023;6(3):12501–19. Available from: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/60636
Pérez-Ramírez M, Bonilla-Delgado J, Godínez-Aguilar R, Victoria-Acosta G, Palma-Lara I, Palacios-Reyes C. Hereditary cancer: participant genes and genetic diagnosis. Rev Hosp Juarez Mex. 2020;87(4). Available from: https://web.archive.org/web/20210428083533id_/https://www.revistahospitaljuarez.com/files/rhjm_20_87_4_203-213.pdf
American Cancer Society. Cancer syndromes in families. [Online]; 2022. Accessed February 2, 2024. Available from: https://www.cancer.org/es/cancer/prevencion-del-riesgo/genetica/sindromes-de-cancer-familiar.html.
MD Anderson Cancer Center. Hereditary cancer syndromes. [Online]; 2020. Accessed February 2, 2024. Available from: https://mdanderson.es/el-cancer/prevencion/sindromes-de-cancer-hereditario.
Easton DF, Pharoah PD, Antoniou AC, et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med. 2015;372(23):2243-2257. doi:10.1056/NEJMsr150134.
Vande Perre P, Imbert-Bouteille M, Pujol P. Oncogenetics: hereditary breast cancers. EMC - Gynecology-Obstetrics [Online]. 2019; 55(3) 1-14. DOI: https://doi.org/10.1016/S1283-081X(19)42497-1. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1283081X19424971
Achig K, Cabrera M, Acosta M, et al. Hereditary breast cancer related to mutations in BRCA1/BRCA2: A systematic review. RECIAMUC. [Online]; 2023; 7(1). Available from: https://reciamuc.com/index.php/RECIAMUC/article/view/1151
Oliver Pérez R, de Miguel Reyes M, Robles Díaz L, Vivares López A, Baeza Hernández G, Ferrández CS, et al. Gynecological tumors in patients with BRCA1 and BRCA2 mutations. Rev Senol Patol Mam. [Online]; 2020; 33(3). Available from: https://www.elsevier.es/es-revista-revista-senologia-patologia-mamaria--131-articulo-tumores-ginecologicos-pacientes-portadoras-mutacion-S0214158220300293
Santos M, Moya M, Oliva J, et al. Hereditary breast cancer associated with mutations BRCA1/BRCA2: Asystematic review. RECIAMUC. [Online]; 2023; 1(1). Available from: https://reciamuc.com/index.php/RECIAMUC/article/download/1151/1822/
Chavarría Campos GF, Blanco Naranjo EG, Garita Fallas YM. Breast cancer associated with mutations in BRCA-1 and BRCA-2 genes. Rev Med Sinergia. [Online]; 2021; 6(3). 9. Available from: https://revistamedicasinergia.com/index.php/rms/article/view/650
Sánchez-Delgado J, Sánchez-Lara N. Family aggregation and risk factors for breast cancer in affected individuals. Rev Enferm No Transm Finlay. 2020; 10(2). Available from: https://revfinlay.sld.cu/index.php/finlay/article/view/770
Arceo M, López J, Ochoa A, Palomera Z. Current status of breast cancer in Mexico: main types and risk factors. Gac. Mex. Oncol. [Online]; 2021; 20(3). Available from: https://www.scielo.org.mx/scielo.php?pid=S2565-005X2021000300101&script=sci_abstract
Cifuentes L, Rivera A, Barreto G. Mutations in BRCA1 and BRCA2 genes in a sample of families with breast and/or ovarian cancer from the Colombian Pacific. Colomb Med [Online]; 2019; 50(3). Available from: http://www.scielo.org.co/scielo.php?script=sci_abstract&pid=S1657-95342019000300163&lng=pt&nrm=iso&tlng=es
Almeida K, Castillo A, Fuertes R, Rodríguez D. Breast cancer linked to the BRCA1 gene. RECIMUNDO [Online]; 2020; 4(1). Available from: https://www.recimundo.com/index.php/es/article/view/783
Gonzáles-Huerta L, Hernández-Vázquez J, Toral-López A, et. al. Relevancia de la secuenciación de nueva generación en el diagnóstico de cáncer de mama y dos mutaciones descritas por primera vez en población mexicana. Salud pública de México [Online]; 2023; 1(1). Available from: https://www.saludpublica.mx/index.php/spm/article/view/14026
Araya Oviedo A, Paizano Vanega G. Ovarian cancer. Rev Med Sinergia [Online]; 2021; 6(7). Available from: https://www.revistamedicasinergia.com/index.php/rms/article/view/690
Arias A, Arin D, Barbierato M, Maffioli A, Pérez M, Queirolo M, et al. Medical genomics contribution in clinical decisions in oncology (monograph). Universidad de la República Uruguay [Online]; 2021. Available from: https://revistas.udelar.edu.uy/OJS/index.php/anfamed/article/view/697/659
Manuel RA. Genetic bases of cancer and main hereditary predisposition syndromes to cancer. NPunto. Dialnet [Online]; 2022; 5(56). Available from: https://dialnet.unirioja.es/servlet/articulo?codigo=8949597
Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek S, et al. Genetic/Familial High-Risk Assessment: Breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice Guidelines in oncology. J Natl Compr Canc Netw [Online]. 2021;19(1):77–102. Available from: https://jnccn.org/view/journals/jnccn/19/1/article-p77.xml
Araya Oviedo A, Paizano Vanega G. Ovarian cancer. Rev Med Sinergia [Online]; 2021; 6(7). Available from: https://www.revistamedicasinergia.com/index.php/rms/article/view/690
Cortés Morera A, Ibáñez Morera M, Hernández Lara A, García Carranza MA. Ovarian Cancer: Screening and Imaging Diagnosis. Rev Med Leg Costa Rica [Online] 2020; 37(1). Available from: https://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00152020000100054
Margarit S. Hereditary breast cancer. Rev Chil Radiol [Online]; 2008; 14(3). Available from: https://www.scielo.cl/scielo.php?pid=S0717-93082008000300006&script=sci_arttext
Guillén‐Ponce C, Lastra E, Lorenzo-Lorenzo I, Martín Gómez T, Morales Chamorro R, Sánchez-Heras AB, Serrano R, Soriano Rodríguez MC, Soto JL, Robles L. SEOM clinical guideline on hereditary colorectal cancer (2019). [Online]; 2020. Available from: https://pubmed.ncbi.nlm.nih.gov/31981079/
ESMO. Colorectal cancer. [Online]; 2016. Accessed February 25, 2024. Available from: https://docs.google.com/viewer?url=https%3A%2F%2Fwww.esmo.org%2Fcontent%2Fdownload%2F15728%2F270764%2F1%2FES-Cancer-Colorrectal-Guia-para-Pacientes.pdf.
MOC. Manual of Clinical Oncology in Brazil, Solid Tumors. [Online]; 2013. Available from: https://mocbrasil.com/es/files/2010/03/MOC2013_TS_ESP1.pdf.
Aguirre Ortega E, et al. SEOM Hereditary Cancer 3rd edition. [Online]; 2019. Available from: https://seom.org/publicaciones/publicaciones-seom/cancer-hereditario
Castro Mujica MC, Barletta-Carrillo C. Lynch syndrome: genetic, clinical, and diagnostic aspects. [Online].; 2018. Accessed February 5, 2024. Available from: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292018000300008&lng=es.
Hampel H, Bennett RL, Buchanan A, et al. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med. 2015;17(1):70-87. doi:10.1038/gim.2014.147.
Instituto Nacional del Cáncer. National Cancer Institute. [Online]; 2024. Accessed February 7, 2024. Available from: https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/poliposis-adenomatosa-familiar-clasica.
Fuentes Mera L, Kawa Karasik S, Leyva Leyva M. Genetic and molecular aspects of familial adenomatous polyposis. ResearchGate. 2009; 21(1). Available from: https://www.researchgate.net/publication/335050297_Abstract_876_CD40-induced_growth_inhibition_of_Burkitt_lymphoma_A_possible_role_for_NADPH_oxidase_by_upregulation_of_p67phox
Corrales Monge S, Solórzano Herra S. The importance of genetic counseling in breast cancer. [Online]; 2020. Accessed February 7, 2024. Available from: https://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00152020000100093
Home: Ingenta Connect [Internet]. Endometrial Cancer as a Familial Tumor: Pathology and Molecular C...: Ingenta Connect; [consulted on May 6, 2024]. Available from: https://www.ingentaconnect.com/content/ben/cg/2009/00000010/00000002/art00007
Published
Issue
Section
License
Copyright (c) 2024 Karina I. Paredes-Páliz, Brando Cruz Mayorga, Érika Peñafiel Ramos, Anabell Urbina Salazar, Alberto Inca Torres (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
